128 related articles for article (PubMed ID: 15467194)
1. The inhibitory effect of intestinal bacterial metabolite of ginsenosides on CYP3A activity.
Liu Y; Li W; Li P; Deng MC; Yang SL; Yang L
Biol Pharm Bull; 2004 Oct; 27(10):1555-60. PubMed ID: 15467194
[TBL] [Abstract][Full Text] [Related]
2. Ginsenoside metabolites, rather than naturally occurring ginsenosides, lead to inhibition of human cytochrome P450 enzymes.
Liu Y; Zhang JW; Li W; Ma H; Sun J; Deng MC; Yang L
Toxicol Sci; 2006 Jun; 91(2):356-64. PubMed ID: 16547074
[TBL] [Abstract][Full Text] [Related]
3. Microsomal cytochrome p450-mediated metabolism of protopanaxatriol ginsenosides: metabolite profile, reaction phenotyping, and structure-metabolism relationship.
Hao H; Lai L; Zheng C; Wang Q; Yu G; Zhou X; Wu L; Gong P; Wang G
Drug Metab Dispos; 2010 Oct; 38(10):1731-9. PubMed ID: 20639434
[TBL] [Abstract][Full Text] [Related]
4. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes.
He N; Edeki T
Am J Ther; 2004; 11(3):206-12. PubMed ID: 15133536
[TBL] [Abstract][Full Text] [Related]
5. Ginsenoside-mediated blockade of 1α,25-dihydroxyvitamin D3 inactivation in human liver and intestine in vitro.
Deb S; Chin MY; Adomat H; Guns ES
J Steroid Biochem Mol Biol; 2014 May; 141():94-103. PubMed ID: 24486455
[TBL] [Abstract][Full Text] [Related]
6. Effects of antidepressant drugs on the activity of cytochrome P-450 measured by caffeine oxidation in rat liver microsomes.
Danie WA; Syrek M; Ryłko Z; Wójcikowski J
Pol J Pharmacol; 2001; 53(4):351-7. PubMed ID: 11990081
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant effects of protopanaxadiol and protopanaxatriol saponins from ginseng roots on the immune responses to ovalbumin in mice.
Sun J; Hu S; Song X
Vaccine; 2007 Jan; 25(6):1114-20. PubMed ID: 17069940
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of twenty-one ginsenosides and their three aglycones in rat plasma by a developed UFLC-MS/MS assay: Application to a pharmacokinetic study of red ginseng.
Zhou QL; Zhu DN; Yang YF; Xu W; Yang XW
J Pharm Biomed Anal; 2017 Apr; 137():1-12. PubMed ID: 28086165
[TBL] [Abstract][Full Text] [Related]
9. Ginsenosides 20(S)-protopanaxadiol and Rh2 reduce cell proliferation and increase sub-G1 cells in two cultured intestinal cell lines, Int-407 and Caco-2.
Popovich DG; Kitts DD
Can J Physiol Pharmacol; 2004 Mar; 82(3):183-90. PubMed ID: 15052284
[TBL] [Abstract][Full Text] [Related]
10. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
11. Ginsenosides of the protopanaxatriol group cause endothelium-dependent relaxation in the rat aorta.
Kang SY; Schini-Kerth VB; Kim ND
Life Sci; 1995; 56(19):1577-86. PubMed ID: 7723586
[TBL] [Abstract][Full Text] [Related]
12. Evidence for involvement of human CYP3A in the 3-hydroxylation of quinine.
Zhang H; Coville PF; Walker RJ; Miners JO; Birkett DJ; Wanwimolruk S
Br J Clin Pharmacol; 1997 Mar; 43(3):245-52. PubMed ID: 9088578
[TBL] [Abstract][Full Text] [Related]
13. Grapefruit component interacting with rat and human P450 CYP3A: possible involvement of non-flavonoid components in drug interaction.
Fukuda K; Ohta T; Yamazoe Y
Biol Pharm Bull; 1997 May; 20(5):560-4. PubMed ID: 9178939
[TBL] [Abstract][Full Text] [Related]
14. Effect of buprenorphine on CYP3A activity in rat and human liver microsomes.
Ibrahim RB; Wilson JG; Thorsby ME; Edwards DJ
Life Sci; 2000 Feb; 66(14):1293-8. PubMed ID: 10755464
[TBL] [Abstract][Full Text] [Related]
15. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.
Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM
Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722
[TBL] [Abstract][Full Text] [Related]
16. In vitro effect of standardized ginseng extracts and individual ginsenosides on the catalytic activity of human CYP1A1, CYP1A2, and CYP1B1.
Chang TK; Chen J; Benetton SA
Drug Metab Dispos; 2002 Apr; 30(4):378-84. PubMed ID: 11901090
[TBL] [Abstract][Full Text] [Related]
17. Analysis of ginsenosides by chromatography and mass spectrometry: release of 20 S-protopanaxadiol and 20 S-protopanaxatriol for quantitation.
Cui JF; Garle M; Lund E; Björkhem I; Eneroth P
Anal Biochem; 1993 May; 210(2):411-7. PubMed ID: 8512077
[TBL] [Abstract][Full Text] [Related]
18. The multidrug resistance modulator valspodar (PSC 833) is metabolized by human cytochrome P450 3A. Implications for drug-drug interactions and pharmacological activity of the main metabolite.
Fischer V; Rodríguez-Gascón A; Heitz F; Tynes R; Hauck C; Cohen D; Vickers AE
Drug Metab Dispos; 1998 Aug; 26(8):802-11. PubMed ID: 9698296
[TBL] [Abstract][Full Text] [Related]
19. Drug interactions with calcium channel blockers: possible involvement of metabolite-intermediate complexation with CYP3A.
Ma B; Prueksaritanont T; Lin JH
Drug Metab Dispos; 2000 Feb; 28(2):125-30. PubMed ID: 10640508
[TBL] [Abstract][Full Text] [Related]
20. Differential effect of bovine serum albumin on ginsenoside metabolite-induced inhibition of alpha3beta4 nicotinic acetylcholine receptor expressed in Xenopus oocytes.
Lee JH; Jeong SM; Lee BH; Kim DH; Kim JH; Kim JI; Lee SM; Nah SY
Arch Pharm Res; 2003 Oct; 26(10):868-73. PubMed ID: 14609137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
